Cellular & Molecular Faculty
| Name | Campus | Specialty | |
|---|---|---|---|
| Alexandru Almasan | CCF | Ph.D., University of South Carolina. Genotoxic stress-induced signals for cell cycle control and cell death. More on Almasan | |
| Mohammad Ansari | NEOMED | More on Ansari | |
| Julie Aultman | NEOMED | More on Aultman | |
| Soumitra Basu | Kent | Quadraplex structures, insulin binding, gene structures and function. More on Basu | |
| Joseph Bedont | Kent | sleep; circadian rhythms; metabolism; autophagy; polyamines; nitrogen stress. More on Bedont | |
| Cornelia Bergmann | CCF | More on Bergmann | |
| Heather Caldwell | Kent | Role of neuropeptides in regulating social behaviors and neuropsychiatric disorders. More on Caldwell | |
| Yeong-Renn Chen | NEOMED | Oxygen free radicals, Nitric oxide, oxidative postranslational modifications, mitochondrial biology in myocardial infarction. More on Chen | |
| William Chilian | NEOMED | Angiogenesis, arteriogenesis, regulation of coronary blood flow, heart failure, stem cells, regenerative medicine. More on Chilian | |
| Chi-hua Chiu Groff | Kent | More on Chiu Groff | |
| Wilson Chung | Kent | Neuroendocrine brain, androgens, fibroblast growth factor signaling. More on Chung | |
| Robert Clements | Kent | More on Clements | |
| Lique Coolen | Kent | Mechanisms by which spinal cord injury affects urogenital and sexual function, neurobiology of addiction and understanding neural circuits that mediate female reproductive function and dysfunction. More on Coolen | |
| Lisa Cooper | NEOMED | More on Cooper | |
| John Crabb | CCF | More on Crabb | |
| Samuel Crish | NEOMED | Glaucoma, axonal transport, structure and function. More on Crish | |
| Mark Dalman | Kent | More on Dalman | |
| Bansidhar Datta | Kent | More on Datta | |
| Dimitrios Davalos | CCF | The Dimitrios Davalos lab studies the interactions between blood vessels, neurons and microglia in health and disease. More on Davalos | |
| Angelo Delucia | NEOMED | Molecular biology of DNA tumor viruses, genetics of viral DNA replication, viral etiology of cancer. More on Delucia | |
| Christine Dengler-Crish | NEOMED | Early disease mechanisms in dementia; sensory system disruptions and homeostatic dysregulation in Alzheimer's disease. More on Crish | |
| Feng Dong | NEOMED | More on Dong | |
| Jean Engohang-Ndong | Kent | More on Engohang-Ndong | |
| Serpil Erzurum | CCF | More on Erzurum | |
| Jessica Ferrell | NEOMED | Long-term research interests lie in examining the pathological disruptions to bile acid physiology that contribute to alcoholic- and non-alcoholic fatty liver disease. We are also interested in studying the interactions between liver/gut metabolism and Alzheimer’s disease, as Type 2 diabetes, cholesterol homeostasis, and gut dysbiosis are thought to be involved in disease progression, while bile acids and their receptors may be novel therapeutic targets. | |
| Sheila Fleming | NEOMED | ||
| Alexander Galazyuk | NEOMED | Neuroscience of hearing. More on Galazyuk | |
| Rebecca German | NEOMED | Neurophysiology and biomechanics. Regulation of feeding and pathophysiology of dysphagia. More on German | |
| Candece Gladson | CCF | More on Gladson | |
| Adam Goodwill | NEOMED | Mechanisms of coronary flow control, studies of cardiac function and identification of cardioprotective pathways. More on Goodwill | |
| Tariq Haqqi | NEOMED | More on Haqqi | |
| James Hardwick | NEOMED | More on Hardwick | |
| Elda Hegmann | Kent | More on Hegmann | |
| Tobin Hieronymus | NEOMED | Pattern and process of skeletal evolution in vertebrates. More on Hieronymus | |
| Min-Ho Kim | Kent | Nanomedicine strategies towards the treatment of diseases including drug-resistant bacterial infections, chronic wounds, and Alzheimer's disease. More on Kim | |
| Woo Yang Kim | Kent | Brain development, neurodevelopmental disorders, autism, intellectual disability, brain circuit, neural stem cell. More on Kim | |
| Edgar Kooijman | Kent | Biophysics protein/lipid interactions, physical chemistry of lipid structure and function, model membranes, neutral lipid storage (lipid droplets/adipocytes). More on Kooijman | |
| Gary Koski | Kent | Immune system and cancer, vaccines, molecular mechanisms. More on Koski | |
| Vijay Krishna | CCF | More on Krishna | |
| Manabu Kurokawa | Kent | ||
| Sangeet Lamichhaney | Kent |
Our lab is broadly interested in understanding how an organism responds to novel environments. We integrate a variety of interdisciplinary approaches, including comparative ‘omics’ (Genomics, Transcriptomics, Epigenomics and Metabolomics), together with experimental physiology to uncover the molecular basis underlying the processes of adaptation. More on Lamichhaney |
|
| Yoon-Kwang Lee | NEOMED | Structure and regulation of nuclear hormone receptors. More on Lee | |
| Laura Leff | Kent | Molecular ecology of bacteria, bacterial enumeration and identification. More on Leff | |
| William Lynch | NEOMED | Mechanisms of neurodegeneration, CNS gene therapy, RNA tumor virus assembly and pathogenesis, microglial developmental biology. More on Lynch | |
| Hanbin Mao | Kent | More on Mao | |
| Ryota Matsuoka | CCF |
Developmental neuroscience, brain barriers, brain-blood communications, brain vascular cell heterogeneity, neurovascular morphogenesis, and cerebrovascular diseases. More on Matsuoka |
|
| Jennifer McDonough | Kent | Regenerative medicine, mitochondrial dysfunction and epigenetic mechanisms in multiple sclerosis. More on McDonough | |
| Jeffrey Mellott | NEOMED | Age-related changes to inhibitory circuitry in the auditory pathways. More on Mellott | |
| Michael Model | Kent | Apoptosis, cell water and volume regulation, membrane potential. More on Model | |
| Xiaozhen Mou | Kent | Metatranscriptomics of bacteria, pathogens in ecosystem. More on Mou | |
| Devin Mueller | Kent | Neural mechanisms of learning and memory that underlie drug use and emotional regulation. More on Mueller | |
| Colleen Novak | Kent | Neural and endocrine mechanisms of activity thermogenesis in obesity. More on Novak | |
| Christine O'Connor | CCF | More on O'Connor | |
| Vahagn Ohanyan | NEOMED | More on Ohanyan | |
| Heather O'Leary | holeary@neomed.edu | NEOMED | More on O'Leary |
| Moses Oyewumi | NEOMED | Drug delivery, nanotechnology, cancer, neurodegenerative diseases. More on Oyewumi | |
| Richard Piet | Kent | Neurophysiological mechanisms involved in regulating the activity of the gonadotropin releasing hormone (GnRH) neurons and their contributions to biological timing and fertility. More on Piet | |
| Helen Piontkivska | Kent | Comparative and evolutionary genomics, bioinformatics, molecular evolution. More on Piontkivska | |
| Gunnar Poplawski | CCF | Translational therapies for neurodegenerative diseases, stem cell and gene therapies for spinal cord injury, in vitro and in vivo models of glioblastomas, hIPSC derived neurons to study regeneration. More on Poplawski | |
| Priya Raman | NEOMED | My lab is interested in the cellular and molecular mechanisms underlying vascular complications and Alzheimer's disease-related dementia associated with diabetes and obesity. We are studying the role of a post-translational protein modification (O-Glycosylation) and a proatherogenic matricellular protein (Thrombospondin-1) in vascular smooth muscle cell phenotypic changes and seeking to understand how targets contributed to vascular and cognitive anomalies in metabolic disorders. More on Raman | |
| Erin Reed-Geaghan |
|
NEOMED | My lab is interested in the role of the immune system in Alzheimer’s disease (AD). Specifically, we seek to understand the ways in which the brain’s resident immune cells, microglia, contribute to the neuroinflammatory processes driving neurodegeneration. We believe microglia from men and women respond differently in AD, contributing to the sex differences in disease onset and progression, and we’re working on identifying the reasons for these differences. We are also interested in how these cells communicate with the circulating peripheral immune system, and the ways in which these interactions affect disease progression |
| Merri Rosen | NEOMED | Effects of developmental stress and hearing loss on auditory perception and neural circuity. More on Rosen | |
| Mary Russell | Kent | Intermediate filament protein synemin, heart, protein kinases. More on Russell | |
| Prabodh Sadana | NEOMED | Hormonal regulation of lipid metabolism. More on Sadana | |
| Fayez Safadi | NEOMED | Osteoblast development and function, effects of hormones and growth factors. More on Safadi | |
| Thorsten-Lars Schmidt | Kent | DNA nanotechnology-based tools and materials for single-molecule biophysics and nanomedicine. More on Schmidt | |
| Brett Schofield | NEOMED | Functional anatomy of auditory pathways. More on Schofield | |
| Sharad Shanbhag | NEOMED | The amygdala's role in vocal communication. More on Shanbhag | |
| Woo-Shik Shin (Austin) | NEOMED |
Novel combination antibacterial therapy against drug resistance ESKAPE pathogens. Drug repurposing and combinational approach to block abnormal protein aggregation in Alzheimer’s disease. |
|
| Robert Silverman | CCF | More on Silverman | |
| Apollo Stacy | CCF | More on Stacy | |
| J.G.M. Thewissen | NEOMED | Mammalian anatomy and evolution, morphological adaptations such as those for swimming and flight. More on Thewissen | |
| Anthony Tosi | Kent | More on Tosi | |
| Bruce Trapp | CCF | More on Trapp | |
| Sean Veney | Kent | Behavioral neuroendocrinology, sexual differentiation of the brain, syrinx anatomy, neuroethology of birdsong. More on Veney | |
| Srinivasan Vijayaraghavan | Kent | Signal transduction, sperm physiology, fertilization, contraception. More on Vijayaraghavan | |
| Xinwen Wang | NEOMED | One size does not fit all. For many patients, standard drug treatment might not work or even trigger life-threatening adverse reactions. There is an urgent clinical need to provide tailored therapy for patients. Our laboratory focuses on applying pharmaco-omics tools (i.e. pharmacogenomics, proteomics and metabolomics) to identify both genetic and non-genetic factors contributing to the interindividual variability related to disease risks and drug therapies. Our research is expected to improve the efficacy and safety of drugs by identifying biomarkers that can predict individual drug responses, revealing novel drug targets and translating these findings into clinical precision pharmacotherapy. More on Wang | |
|
Jeffrey Wenstrup |
NEOMED | Neural mechanisms of hearing, acoustic communication, including emotional responses to sound. More on Wenstrup | |
| Jessica Williams | CCF | More on Williams | |
| Bradley Winters | NEOMED | Cellular neurophysiology of brainstem sound localization circuits that process timing and intensity differences between the two ears. More on Winters | |
| Liya Yin | NEOMED | More on Yin | |
| Jesse Young | NEOMED | Comparative and developmental biomechanics of locomotion. More on Young | |
| Ping Zhang | NEOMED | More on P. Zhang | |
| Yanqiao Zhang | NEOMED | Regulation of lipid and glucose metabolism under normal and disease conditions. More on Zhang |